NKAIN2 inhibitors represent a class of chemical compounds that specifically interact with the NKAIN2 (Na+/K+ transporting ATPase interacting 2) protein to modulate its activity. NKAIN2 is part of a family of transmembrane proteins that are believed to play a role in regulating ion transport across cell membranes, particularly in the nervous system. These proteins interact with the Na+/K+ ATPase, an enzyme critical for maintaining the electrochemical gradients of sodium and potassium ions across the plasma membrane. By inhibiting NKAIN2, these compounds influence the protein's interaction with the Na+/K+ ATPase, potentially altering ion flux and cellular processes tied to ion transport.
Structurally, NKAIN2 inhibitors vary, but they typically exhibit characteristics that enable them to bind to the NKAIN2 protein with specificity and high affinity. These compounds may have complex ring structures, halogen substitutions, or other functional groups that facilitate their binding to key sites on the NKAIN2 protein. The binding can result in conformational changes within the protein, thereby affecting its ability to interact with the Na+/K+ ATPase. The modulation of NKAIN2 activity by these inhibitors can be studied using various biochemical and biophysical techniques, including binding assays, protein structural analysis, and electrophysiological studies to assess changes in ion transport. These inhibitors are valuable tools for exploring the physiological roles of NKAIN2 and its interactions with other proteins in cellular systems, particularly in research focused on ion channel regulation and membrane transport.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a specific inhibitor of the Na⁺/K⁺-ATPase pump. NKAIN2 is known to associate with the sodium/potassium-transporting ATPase subunits. By inhibiting this pump, ouabain disrupts the ionic homeostasis that NKAIN2 helps regulate. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin targets Na⁺/K⁺-ATPase. NKAIN2's interaction with the Na⁺/K⁺ pump suggests that inhibition of the pump by digoxin would disrupt NKAIN2's role in neuronal electrochemical gradient maintenance, thereby inhibiting NKAIN2. | ||||||
Bufalin | 465-21-4 | sc-200136 sc-200136A sc-200136B sc-200136C | 10 mg 25 mg 50 mg 100 mg | $99.00 $204.00 $341.00 $544.00 | 5 | |
Bufalin is a cardiotonic steroid that inhibits Na⁺/K⁺-ATPase, which NKAIN2 is associated with. The inhibition of Na⁺/K⁺-ATPase by bufalin would disrupt NKAIN2's ability to regulate ion transport across neuronal membranes. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A binds to and inhibits Na⁺/K⁺-ATPase. As NKAIN2 functions in conjunction with this pump, concanavalin A's inhibition of Na⁺/K⁺-ATPase would consequently inhibit the regulatory role of NKAIN2. | ||||||
Strophanthidin | 66-28-4 | sc-215914 sc-215914A | 250 mg 1 g | $215.00 $692.00 | 2 | |
Strophanthidin is known to inhibit Na⁺/K⁺-ATPase. By inhibiting this enzyme, strophanthidin would disrupt the ionic balance that NKAIN2 is implicated in managing, thereby leading to a functional inhibition of NKAIN2. | ||||||